BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1319 related articles for article (PubMed ID: 17307972)

  • 1. Ca2+ channel subtypes and pharmacology in the kidney.
    Hayashi K; Wakino S; Sugano N; Ozawa Y; Homma K; Saruta T
    Circ Res; 2007 Feb; 100(3):342-53. PubMed ID: 17307972
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Renal microcirculation and calcium channel subtypes.
    Homma K; Hayashi K; Yamaguchi S; Fujishima S; Hori S; Itoh H
    Curr Hypertens Rev; 2013 Aug; 9(3):182-6. PubMed ID: 24479750
    [TBL] [Abstract][Full Text] [Related]  

  • 3. T-type calcium channels in the regulation of afferent and efferent arterioles in rats.
    Feng MG; Li M; Navar LG
    Am J Physiol Renal Physiol; 2004 Feb; 286(2):F331-7. PubMed ID: 14583435
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional and pharmacological consequences of the distribution of voltage-gated calcium channels in the renal blood vessels.
    Hansen PB
    Acta Physiol (Oxf); 2013 Apr; 207(4):690-9. PubMed ID: 23351056
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of T-type selective calcium antagonist on renal microcirculation: studies in the isolated perfused hydronephrotic kidney.
    Ozawa Y; Hayashi K; Nagahama T; Fujiwara K; Saruta T
    Hypertension; 2001 Sep; 38(3):343-7. PubMed ID: 11566902
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Renal protective action of T-, L-, and N-type Ca channel blockers].
    Hayashi K
    Nihon Rinsho; 2004 Mar; 62 Suppl 3():654-61. PubMed ID: 15171451
    [No Abstract]   [Full Text] [Related]  

  • 7. T-type Ca channel blockade as a determinant of kidney protection.
    Hayashi K; Homma K; Wakino S; Tokuyama H; Sugano N; Saruta T; Itoh H
    Keio J Med; 2010; 59(3):84-95. PubMed ID: 20881449
    [TBL] [Abstract][Full Text] [Related]  

  • 8. T-type Ca channel blockers in patients with chronic kidney disease in clinical practice.
    Abe M; Okada K; Soma M
    Curr Hypertens Rev; 2013 Aug; 9(3):202-9. PubMed ID: 24479749
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathophysiological significance of T-type Ca2+ channels: role of T-type Ca2+ channels in renal microcirculation.
    Hayashi K; Wakino S; Homma K; Sugano N; Saruta T
    J Pharmacol Sci; 2005 Nov; 99(3):221-7. PubMed ID: 16293936
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blockade of T-type voltage-dependent Ca2+ channels by benidipine, a dihydropyridine calcium channel blocker, inhibits aldosterone production in human adrenocortical cell line NCI-H295R.
    Akizuki O; Inayoshi A; Kitayama T; Yao K; Shirakura S; Sasaki K; Kusaka H; Matsubara M
    Eur J Pharmacol; 2008 Apr; 584(2-3):424-34. PubMed ID: 18331727
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vascular effects of calcium channel antagonists: new evidence.
    Richard S
    Drugs; 2005; 65 Suppl 2():1-10. PubMed ID: 16398057
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of L-type and mixed L- and T-type calcium channel blockers on kidney injury caused by deoxycorticosterone-salt hypertension in rats.
    Baylis C; Qiu C; Engels K
    Am J Kidney Dis; 2001 Dec; 38(6):1292-7. PubMed ID: 11728963
    [TBL] [Abstract][Full Text] [Related]  

  • 13. L/N-type calcium channel blocker cilnidipine ameliorates proteinuria and inhibits the renal renin-angiotensin-aldosterone system in deoxycorticosterone acetate-salt hypertensive rats.
    Toba H; Yoshida M; Tojo C; Nakano A; Oshima Y; Kojima Y; Noda K; Wang J; Kobara M; Nakata T
    Hypertens Res; 2011 Apr; 34(4):521-9. PubMed ID: 21270815
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nitric oxide synthase inhibition activates L- and T-type Ca2+ channels in afferent and efferent arterioles.
    Feng MG; Navar LG
    Am J Physiol Renal Physiol; 2006 Apr; 290(4):F873-9. PubMed ID: 16263803
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Divergent natriuretic action of calcium channel antagonists in mongrel dogs: renal haemodynamics as a determinant of natriuresis.
    Honda M; Hayashi K; Matsuda H; Kubota E; Tokuyama H; Okubo K; Ozawa Y; Saruta T
    Clin Sci (Lond); 2001 Oct; 101(4):421-7. PubMed ID: 11566080
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Investigational calcium channel blockers for the treatment of hypertension.
    Tamargo J; Ruilope LM
    Expert Opin Investig Drugs; 2016 Nov; 25(11):1295-1309. PubMed ID: 27696904
    [TBL] [Abstract][Full Text] [Related]  

  • 17. T-type voltage-gated calcium channels regulate the tone of mouse efferent arterioles.
    Poulsen CB; Al-Mashhadi RH; Cribbs LL; Skøtt O; Hansen PB
    Kidney Int; 2011 Feb; 79(4):443-51. PubMed ID: 21068717
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of L- and T-type calcium channels in local and remote calcium responses in rat mesenteric terminal arterioles.
    Braunstein TH; Inoue R; Cribbs L; Oike M; Ito Y; Holstein-Rathlou NH; Jensen LJ
    J Vasc Res; 2009; 46(2):138-51. PubMed ID: 18765948
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aldosterone and the kidney: rapid regulation of renal microcirculation.
    Arima S
    Steroids; 2006 Apr; 71(4):281-5. PubMed ID: 16289172
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Pleiotropic effects of new generation calcium channel blockers on cardiovascular protections].
    Ogimoto A; Higaki J
    Clin Calcium; 2013 Apr; 23(4):569-74. PubMed ID: 23545747
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 66.